EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf

View source ↗

Summary

Authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis Allergic Perennial
• Rhinitis Allergic Seasonal
• Urticaria

Drugs mentioned

• Desloratadine Actavis (desloratadine)

Snippet

Status: Authorised. Therapeutic area: Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal. MAH: Actavis Group PTC ehf. Decision date: 02/07/2026